{
  "id": "fda-greenlights-human-trials-of-serina-s-parkinson-s-drug",
  "title": "FDA greenlights human trials of Serina’s Parkinson’s drug",
  "summary": "Juvenescence-backed biotech targets ‘continuous dopaminergic stimulation’ to reduce the severity of motor complications in Parkinson’s. US biotech Serina Therapeutics has received clearance from the FDA to begin human trials of its long-acting apomorphine therapy designed for people with advanced Parkinson’s disease. The approval of the company’s investigational new drug application opens the door for a […] The post FDA greenlights human trials of Serina’s Parkinson’s drug appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/fda-greenlights-human-trials-of-serinas-parkinsons-drug/",
  "source": "Longevity.Technology",
  "author": "Danny Sullivan",
  "category": "news",
  "publishedAt": "2026-01-30T16:25:42.000Z",
  "fetchedAt": "2026-02-04T10:49:05.818Z",
  "relevanceScore": 0.2,
  "matchedKeywords": [
    "longevity"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.890Z"
}